Vanguard Group’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $848M | Buy |
|
|||||
|
2021
Q2 | $616M | Sell |
|
|||||
|
2021
Q1 | $688M | Buy |
|
|||||
|
2020
Q4 | $643M | Buy |
|
|||||
|
2020
Q3 | $529M | Buy |
|
|||||
|
2020
Q2 | $413M | Buy |
|
|||||
|
2020
Q1 | $383M | Buy |
|
|||||
|
2019
Q4 | $221M | Sell |
|
|||||
|
2019
Q3 | $165M | Buy |
|
|||||
|
2019
Q2 | $168M | Buy |
|
|||||
|
2019
Q1 | $187M | Buy |
|
|||||
|
2018
Q4 | $153M | Buy |
|
|||||
|
2018
Q3 | $196M | Buy |
|
|||||
|
2018
Q2 | $125M | Buy |
|
|||||
|
2018
Q1 | $97.7M | Buy |
|
|||||
|
2017
Q4 | $103M | Buy |
|
|||||
|
2017
Q3 | $87M | Buy |
|
|||||
|
2017
Q2 | $61.7M | Buy |
|
|||||
|
2017
Q1 | $50.6M | Buy |
|
|||||
|
2016
Q4 | $44.8M | Buy |
|
|||||
|
2016
Q3 | $61M | Buy |
|
|||||
|
2016
Q2 | $55.9M | Buy |
|
|||||
|
2016
Q1 | $38.7M | Buy |
|
|||||
|
2015
Q4 | $61.7M | Buy |
|
|||||
|
2015
Q3 | $30.8M | Buy |
|
|||||
|
2015
Q2 | $27.3M | Buy |
|
|||||
|
2015
Q1 | $30.1M | Buy |
|
|||||
|
2014
Q4 | $30.2M | Buy |
|
|||||
|
2014
Q3 | $22.2M | Buy |
|
|||||
|
2014
Q2 | $23.3M | Buy |
|
|||||
|
2014
Q1 | $13.3M | Buy |
|
|||||
|
2013
Q4 | $5.27M | Buy |
|